Surgical Evacuation Of Spontaneous Intracerebral Hematoma: Clinical Outcomes and Prognostic Factors
1 other identifier
interventional
40
1 country
1
Brief Summary
The aim of this study is to assess the safety and efficacy of surgical evacuation of spontaneous intracerebral hemorrhage.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2022
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2022
CompletedFirst Submitted
Initial submission to the registry
January 30, 2025
CompletedFirst Posted
Study publicly available on registry
February 10, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 30, 2025
CompletedFebruary 11, 2025
February 1, 2025
3.9 years
January 30, 2025
February 7, 2025
Conditions
Outcome Measures
Primary Outcomes (2)
Morbidity after surgical evacuation of Intracerebral hematoma
Complications within first month
1 month
Mortality after surgical evacuation of Intracerebral hematoma
Death of patient within first month
1 month
Secondary Outcomes (2)
Morbidity after surgical evacuation of Intracerebral hematoma
3 months
Mortality after surgical evacuation of Intracerebral hematoma
3 months
Study Arms (1)
Surgical evacuation of Intracerebral hemorrhage
OTHERSurgical evacuation of Intracerebral hematoma
Interventions
Surgical Evacuation of Intracerebral Hemorrhage
Eligibility Criteria
You may qualify if:
- Patients with radiological findings of ICH.
- Age group 20-70 years.
You may not qualify if:
- Traumatic ICH or ruptured aneurysm or AVM or brain tumor.
- Postoperative cranial surgery ICH.
- Secondary hydrocephalus.
- Patients with other comorbidities e.g., Liver cell failure and renal cell failure.
- Patients with bleeding disorders.
- Patients who are regular on anticoagulant or antiplatelet therapy.
- Small sized ICH\< 30 ml.
- GCS less than 6 preoperatively.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Sohag Universitylead
Study Sites (1)
Sohag University hospitals
Sohag, Egypt
Related Publications (3)
van Asch CJ, Luitse MJ, Rinkel GJ, van der Tweel I, Algra A, Klijn CJ. Incidence, case fatality, and functional outcome of intracerebral haemorrhage over time, according to age, sex, and ethnic origin: a systematic review and meta-analysis. Lancet Neurol. 2010 Feb;9(2):167-76. doi: 10.1016/S1474-4422(09)70340-0. Epub 2010 Jan 5.
PMID: 20056489BACKGROUNDWilkinson DA, Pandey AS, Thompson BG, Keep RF, Hua Y, Xi G. Injury mechanisms in acute intracerebral hemorrhage. Neuropharmacology. 2018 May 15;134(Pt B):240-248. doi: 10.1016/j.neuropharm.2017.09.033. Epub 2017 Sep 22.
PMID: 28947377BACKGROUNDWong JM, Ziewacz JE, Ho AL, Panchmatia JR, Kim AH, Bader AM, Thompson BG, Du R, Gawande AA. Patterns in neurosurgical adverse events: open cerebrovascular neurosurgery. Neurosurg Focus. 2012 Nov;33(5):E15. doi: 10.3171/2012.7.FOCUS12181.
PMID: 23116095BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Demonstrator of Neurosurgery
Study Record Dates
First Submitted
January 30, 2025
First Posted
February 10, 2025
Study Start
January 1, 2022
Primary Completion
December 1, 2025
Study Completion
December 30, 2025
Last Updated
February 11, 2025
Record last verified: 2025-02
Data Sharing
- IPD Sharing
- Will not share